Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$434.3K
50K shares
What this filing means
HECHT BETH plans to sell 50K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $434.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009959
Officer· See Remarks
Since Oct 2021
50K
Shares to sell
$434.3K
Approx. market value
16.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
1/29/2023
15.23KOpen Market Purchase
Cash
3/13/2020
1.44KTotal acquired16.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/29/2023 | Restricted Stock Units N/A | 15.23K | — |
3/13/2020 | Open Market Purchase Cash | 1.44K | — |
| Total | 16.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.67K
Market value
$141.4K
9/1/2026
—Completed
Units to sell
16.67K
Market value
$133.6K
8/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.67K
Market value
$159.3K
10/1/2026
Total
Units
50K
Value
$434.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 16.67K | $141.4K | — | Completed |
8/3/2026 | 16.67K | $133.6K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 16.67K | $159.3K | NASDAQ | Planned |
| Total | 50K | $434.3K | ||